The value of pharmacists in health care

Population Health Management

Volumn 15, Issue 3, 2012, Pages 157-162

  Patwardhan, Avinash ^a   Duncan, Ian ^a   Murphy, Patricia ^a   Pegus, Cheryl ^a  

^a Walgreen   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC DISEASE; HEALTH CARE; HUMAN; MEDICAL RESEARCH; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST; QUALITY OF LIFE;

CHRONIC DISEASE; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LEADERSHIP; MEDICATION ADHERENCE; PATIENT CARE; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; PUBLIC HEALTH; QUALITY OF HEALTH CARE; QUALITY OF LIFE; UNITED STATES;

EID: 84863212718     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2011.0030     Document Type: Article

References (33)

1. DeVol R, Bedroussian A. An unhealthy America: The economic burden of chronic disease. Charting a new course to save lives and increase productivity and economic growth. Available at: http://www.milkeninstitute.org/publications/ publications.taf?function = detail&ID= 38801018&cat = resrep. Accessed February 15, 2010.
2. Dill MJ, Salsberg ES. The complexities of physician supply and demand: Projections through 2025. Available at: http:// www.tht.org/education/resources/ AAMC.pdf. Accessed June 10, 2010.
3. US Department of Health and Human Services; Health Resources and Services Administration; Bureau of Health Professions. The physician workforce: Projections and research into current issues affecting supply and demand. Available at: ftp://ftp.hrsa.gov/bhpr/workforce/physician workforce.pdf. Accessed March 15, 2011.
4. U.S. Department of Health and Human Services. Health Resources and Services Administration. Bureau of Health Professions. The adequacy of pharmacist supply: 2004 to 2030. Available at: http://bhpr.hrsa.gov/ healthworkforce/ pharmacy/pharmacistsupply.pdf. Accessed March 15, 2011.
5. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-1155. (Pubitemid 34522403)
6. Sax B. Chain drugstores: Providing effective patient care and professional development. Available at: http://www.pharmacytimes. com/publications/career/2011/PharmacyCareers-Spring2011/ChainDrugstores-2011. Accessed May 3, 2011.
7. Buurma H, De Smet PA, Leufkens HG, Egberts AC. Evaluation of the clinical value of pharmacists modifications of prescription errors. Br J Clin Pharmacol. 2004;58:503-511. (Pubitemid 39540454)
8. Rupp MT. Value of community pharmacists interventions to correct prescribing errors. Ann Pharmacother. 1992; 26:1580-1584.
9. Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47:695-700. (Pubitemid 29257669)
10. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: The Minnesota experience. J Am Pharm Assoc (2003). 2008;48:203-211.
11. Barnett MJ, Frank J, Wehring H, et al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009;15:18-31.
12. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial. JAMA. 2006;296:2563-2571. (Pubitemid 44903860)
13. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530. (Pubitemid 40847288)
14. Rubio-Valera M, Serrano-Blanco A, Magdalena-Belo J, et al. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: A systematic review and metaanalysis. Ann Pharmacother. 2011;45:39-48.
15. Sherman BW, Frazee SG, Fabius RJ, Broome RA, Manfred JR, Davis JC. Impact of workplace health services on adherence to chronic medications. Am J Manag Care. 2009;15:e53-e59.
16. Patwardhan A, Davis J, Murphy P, Khandelwal N, Sherman B, Manfred J. The impact of 90-day prescriptions on adherence at workplace pharmacies compared to traditional mail order. Popul Health Manag. 2011;14:285-291.
17. Cranor CW, Christensen DB. The Asheville Project: Shortterm outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43:149-159.
18. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: Long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43:173-184.
19. Fera T, Bluml BM, Eliis WM, Schaller CW, Garrett DG. The Diabetes Ten City Challenge: Interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc (2003). 2008;48:181-190.
20. Divine H, Nicholas A, Johnson CL, Perrier DG, Steinke DT, Blumenschein K. PharmacistCARE: Description of a pharmacist care service and lessons learned along the way. J Am Pharm Assoc (2003). 2008;48:793-802.
21. Johnson KA, Chen S, Cheng I-N, et al. The impact of clinical pharmacy services integrated into medical homes on diabetes-related clinical outcomes. Ann Pharmacother. 2010; 44:1877-1886.
22. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828-1832. (Pubitemid 41527695)
23. Frazee SG, Raulerson WW, Schwab H, et al. Improving health outcomes and reducing cost in chronic disease management: Impact of a pharmacist-led diabetes education program at a workplace pharmacy. Health Productivity Manage. 2010;8:32-36.
24. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: Systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41:1569-1582. (Pubitemid 47479786)
25. Bunting BA, Smith BH, Sutherland SE. The Asheville project: Clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003). 2008;48:23-31.
26. Robinson JD, Segal R, Lopez LM, Doty RE. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother. 2010;44:88-96.
27. Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother. 2004;38:2023-2028. (Pubitemid 40169369)
28. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41:1770-1781. (Pubitemid 350044338)
29. Machado M, Nassor N, Bajcar JM, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part III: Systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42:1195-1207.
30. Bunting BA, Cranor CW. The Asheville project: Long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003). 2006;46:133-147. (Pubitemid 46037370)
31. Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother. 2009;43:85-97.
32. Pickard AS, Hung SY. An update on evidence of clinical pharmacy services impact on health-related quality of life. Ann Pharmacother. 2006;40:1623-1634. (Pubitemid 44330207)
33. National Association of Chain Drug Stores. Pharmacies: Improving health, reducing costs. Available at: http://www. nacds.org/user-assets/pdfs/2011/ PrinciplesOfHealthcare.pdf. Accessed May 3, 2011.